# Massimo Federico

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/massimo-federico/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,353 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 74 |
| i10-index | 257 |
| Last Known Institution | University of Modena and Reggio Emilia |
| OpenAlex ID | https://openalex.org/A5035398527 |
| ORCID iD | https://orcid.org/0000-0002-9889-3796 |
| Works | 552 |

## Researcher papers

- [Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma](https://scholariq.org/papers/adapted-treatment-guided-by-interim-pet-ct-scan-in-advanced-hodgkin-s-lymphoma/)
- [Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project](https://scholariq.org/papers/follicular-lymphoma-international-prognostic-index-2-a-new-prognostic-index-for/)
- [Multicenter Surveillance of Women at High Genetic Breast Cancer Risk Using Mammography, Ultrasonography, and Contrast-Enhanced Magnetic Resonance Imaging (the High Breast Cancer Risk Italian 1 Study)](https://scholariq.org/papers/multicenter-surveillance-of-women-at-high-genetic-breast-cancer-risk-using/)
- [ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial](https://scholariq.org/papers/abvd-compared-with-beacopp-compared-with-cec-for-the-initial-treatment-of/)
- [R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi](https://scholariq.org/papers/r-cvp-versus-r-chop-versus-r-fm-for-the-initial-treatment-of-patients-with/)
- [Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study](https://scholariq.org/papers/incidence-and-clinicopathologic-features-of-gastrointestinal-stromal-tumors-a/)
- [Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies](https://scholariq.org/papers/prognostic-value-of-pet-ct-after-first-line-therapy-in-patients-with-follicular/)
- [PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study](https://scholariq.org/papers/pet-ct-for-staging-and-early-response-results-from-the-response-adapted-therapy/)
- [The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project](https://scholariq.org/papers/the-outcome-of-peripheral-t-cell-lymphoma-patients-failing-first-line-therapy-a/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders-2/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [CNS Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/cns-lymphoma-diagnosis-and-treatment/)

## Researcher university

- [University of Modena and Reggio Emilia](https://scholariq.org/institutions/university-of-modena-and-reggio-emilia/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.